Sinovac Issues 2009 Guidance; Announces Secondary Stock Issue
January 21, 2010 at 07:33 AM EST
Sinovac Biotech (北京科兴生物制品有限公司) released full-year guidance for 2009 and also announced it would issue 8.65 million shares to raise about $62 million in new capital. The company said it expects revenues for 2009 to be between $81 and $85 million, while gross profits will total somewhere in a $61 to $65 million range. More details... Stock Symbol: (NSDQ: SVA)